NFE2L2 and triple-A syndrome: The fact that mitochondria-targeted MitoQ was able to reduce O2- levels in both controls and AngII-challenged healthy VSMCs, but not in AAA-SMCs, suggests involvement of mitochondria in activation of the Nrf2/ARE cascade, as it was demonstrated in cardiomyocytes [46].